NCT01076595View on ClinicalTrials.gov

Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

July 31, 2014

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Betaferon 250 microgram

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01076595 - Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period | Biotech Hunter | Biotech Hunter